# Wall Street’s Key Stock Analysts Research Report, All Buys

Live Trading News is an independent financial media publication. Masthead: Live Trading News. Parent: Knightsbridge Group. Product cousin: KXCO (kxco.ai). Coverage: markets, policy, AI, quantum, blockchain, FX, biotech, ASEAN. New stories are signed ML-DSA-65 and anchored on Armature L1; articles published before the platform launch are not signed. Nothing on the site is investment advice.

Canonical HTML: https://www.livetradingnews.com/wall-streets-key-stock-analysts-research-report-all-buys-278
Last modified: 2021-06-22

---

By Paul Ebeling · 2021-06-22
Tags: Shayne Heffernan on Investments, Stocks, stocks, research, Bullish, analysts, Paul Ebeling, Buys, WallStreet
Signed: no (published before platform launch).
Nothing in this article is investment advice.

#[stocks](https://www.livetradingnews.com/stocks) [#bullish](https://www.livetradingnews.com/tag/bullish) [#buys](https://www.livetradingnews.com/tag/buys) [#analysts](https://www.livetradingnews.com/tag/analysts) [#research](https://www.livetradingnews.com/tag/research) [#WallStreet](https://www.livetradingnews.com/tag/wallstreet)

$ALLO $ESTC $OPK $RIOT $RMD

Daily [HeffX](http://www.heffx.com/)-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new [trading ](https://exante.eu/p/8857/frommup/)and investing ideas for [HeffX](http://www.heffx.com/)-LTN readers. These reports cover [stocks](https://exante.eu/p/8857/frommup/) to [buy](https://clicks.pipaffiliates.com/c?c=229081&l=en&p=0) if you can manage the risk.

[These are all Buys if you can manage the risk.](https://www.livetradingnews.com/if-you-can-manage-the-risk-the-coronavirus-has-presented-opportunity-in-this-market-170367.html#.XnnNuogzYpo)

Below are our Buys for Tuesday, 22 June, as follows:

Allogene Therapeutics, Inc. ([NASDAQ:ALLO](NASDAQ:ALLO)): Jefferies resumed coverage with a Buy rating and a 53 price target. The stock trades in a 52-wk range of 23.30 - 46.85. The consensus price target is at 49.77.

Elastic N.V. ([NYSE:ESTC](NYSE:ESTC)): Summit Insights initiated coverage with a Buy rating and a 180 price target. The shares last closed near 144, and the consensus price target is at 171.39.

OPKO Health Inc. ([NASDAQ:OPK](NASDAQ:OPK)): Ladenburg Thalmann initiated coverage with a Buy rating and a 7 price target. Shares have a consensus price target at 8.25.

Riot Blockbhain, Inc. ([NASDAQ:RIOT](NASDAQ:RIOT)): Compass Point initiated coverage with a Buy rating and a 43 price target. The consensus price target is at 47.94.

ResMed Inc. ([NYSE:RMD](NYSE:RMD)): Needham reiterated a Buy rating and jumped the price target to 267 from 229. The consensus price target is at 218.40. The stock has a 52-wk range of 165.72 - 242.50 and closed Monday at 239.52/share.

Have a happy day, Keep the Faith!

---

This Markdown mirrors https://www.livetradingnews.com/wall-streets-key-stock-analysts-research-report-all-buys-278. The HTML page is canonical.
Site index for AI clients: https://www.livetradingnews.com/llms.txt